Seizure Free Rate: Percentage of Participants Who Did Not Have Any Seizure Episode Within the Last Month of the Maintenance Period (ie, Month 4). [clinicaltrials_resource:NCT01627860/outcome/1]
outcome [clinicaltrials_vocabulary:outcome]
Seizure Free Rate: Percentage of Participants Who Did Not Have Any Seizure Episode Within the Last Month of the Maintenance Period (ie, Month 4). [clinicaltrials_resource:NCT01627860/outcome/1]
Bio2RDF identifier
NCT01627860/outcome/1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:NCT01627860/outcome/1
analysis [clinicaltrials_vocabulary:analysis]
group [clinicaltrials_vocabulary:group]
measure [clinicaltrials_vocabulary:measure]
population [clinicaltrials_vocabulary:population]
Intent-To-Treat population: Al ...... one dose of study medication.
Participants who have received study medication during month 4.
safety issue [clinicaltrials_vocabulary:safety-issue]
time frame [clinicaltrials_vocabulary:time-frame]
Baseline (4 weeks retrospective assessment prior to start of titration period) to Month 4
type [clinicaltrials_vocabulary:type]
alternate
Seizure Free Rate: Percentage ...... ntenance Period (ie, Month 4).
@en
identifier
clinicaltrials_resource:NCT01627860/outcome/1
type
label
Seizure Free Rate: Percentage ...... esource:NCT01627860/outcome/1]
@en